SCHEMBL998431

SCHEMBL998431

Nc1cncc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4607490 0.97 TP53 (0.46)
Formic Acid SCHEMBL27973772 0.87 HCAR2 (0.44)
Formic Acid Methyl Ester SCHEMBL28317412 0.82 KCNH2 (0.36)
SCHEMBL197638 0.78
SCHEMBL187404 0.78
Hydrochloric Acid SCHEMBL3583511 0.76
SCHEMBL30129770 0.76
Hydrochloric Acid SCHEMBL6069542 0.76
Bromide SCHEMBL7898147 0.76 MEN1 (0.50)
SCHEMBL28044800 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119613279-A N-substituted benzene ring bioisostere and preparation method thereof 上海交通大学 2025-03-14 CN claimed
CN-119432148-A Perovskite ink, perovskite film and battery device 云南大学 2025-02-14 CN claimed
EP-2616458-B1 PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS II BASF SE (DE) 2016-07-20 EP claimed
US-20260124222-A1 ISOTHIAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS INC (US) 2026-05-07 US disclosed
US-20260125359-A1 HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS FUJIAN HAIXI PHARMACEUTICALS CO LTD (CN) 2026-05-07 US disclosed
EP-4735430-A1 MALT1 INHIBITORS Janssen Pharmaceutica NV (BE) 2026-05-06 EP disclosed
US-12565496-B2 Substituted 1H-pyrrolo[3,2-b]pyridine compounds and methods of use thereof BAYER AKTIENGESELLSCHAFT (DE) 2026-03-03 US disclosed
US-12528827-B2 Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2026-01-20 US disclosed
US-20250360145-A1 CSF-1R INHIBITORS AND USES THEREOF MYROBALAN THERAPEUTICS INC (US) 2025-11-27 US disclosed
EP-4638445-A1 1,2,4-THIAZOLIDIN-3-ONE-1,1-DIOXIDE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE Bristol-Myers Squibb Company (US) 2025-10-29 EP disclosed
EP-4615836-A1 INHIBITORS OF CYCLIC ADP RIBOSE HYDROLASE METHODS OF USE THEREOF Flagship Pioneering Innovations VI, LLC (US) 2025-09-17 EP disclosed
EP-1575926-A1 NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES Almirall Prodesfarma, S.A. (ES) 2005-09-21 EP disclosed
WO-2004103998-A1 QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-12-02 WO disclosed
WO-2004058729-A1 NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES ALMIRALL PRODESFARMA SA (ES) 2004-07-15 WO disclosed
WO-2001017965-A2 CYANOPIPERIDINES AS PESTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2001-03-15 WO disclosed
EP-0901490-A1 BICYCLIC AMINES AS INSECTICIDES ZENECA LIMITED (GB) 1999-03-17 EP disclosed
WO-1997043286-A1 BICYCLIC AMINES AS INSECTICIDES ZENECA LIMITED (GB) 1997-11-20 WO disclosed
CN-1049770-A Weeding glutaramic acid and its derivative ROHM & HAAS (US) 1991-03-13 CN disclosed
US-4192946-A Process for producing 3-hydroxy-5-halopyridines CIBA-GEIGY CORPORATION (US) 1980-03-11 US disclosed
US-4110458-A N-(PYRIDYL) OXAMIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1978-08-29 US disclosed